Comparing the current results to its competitors, Chemed reported Revenue increase in the 2 quarter 2026 by 8.8 % year on year. The revenue growth was below Chemed's competitors' average revenue growth of 10.74 %, achieved in the same quarter.
Chemed's Comment on Competition and Industry Peers
VITAS encounters competitive challenges in securing certificates or approvals necessary to develop hospice programs in new or existing markets. Competitors may contest these approvals, which could negatively affect VITAS. Changes in Certificate of Need laws may enable additional competitors to enter markets where VITAS operates, potentially impacting its market position. Moratoriums on new hospices or expansions could restrict VITAS' growth. Furthermore, restrictions on for-profit ownership in certain states, including New York, may limit VITAS' expansion opportunities.
June 28, 2025
Balancing Prognostications and Realities: Chemed s Strategic Outlook for 2025 In a city renowned more for its Midwestern charm than corporate machinations, Cincinnati finds itself yet again as the focal point of financial scrutiny. The epicentre of this attention is none other than Chemed Corporation, a formidable presence in the healthcare services domain, trading under the symbol CHE on the New York Stock Exchange. With an announcement made on the cusp of the weekend, Chemed has set its sights on 29th July 2025, as the release date for its second-quarter financial results, capturing the curiosity of investors, analysts, and industry observers alike.The forthcoming release of financial data, pertaining to t...
Addus Homecare Corporation operates as a provider of comprehensive homecare services. The company's business model revolves around offering a wide range of in-home healthcare services to individuals in need, including personal care, skilled nursing, and therapy. Addus Homecare focuses on forming partnerships with government agencies and managed care organizations to deliver cost-effective care solutions to clients.
Enhabit Inc is a sustainable home renovation company that focuses on energy efficiency and comfort. Their business model involves providing homeowners with a comprehensive package of energy assessments, custom designs, and a network of certified contractors, streamlining the home renovation process. By empowering homeowners to make informed decisions, Enhabit aims to create healthier and more sustainable living spaces.
Ensign Group Inc's business model revolves around providing quality healthcare services through its network of skilled nursing and assisted living facilities.
Healthcare Services Group Inc is a company that provides essential services to healthcare facilities, such as housekeeping, food services, and laundry services.
Humana Inc.s business model focuses on providing a wide range of health insurance products and healthcare services to individuals and groups. The company generates revenue primarily through the sale of Medicare, Medicaid, and commercial insurance plans, as well as by operating healthcare facilities and clinics. Their mission is to enhance customer health outcomes by delivering accessible, affordable, and integrated healthcare solutions tailored to the needs of their members.
Sources:
Chemed Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Chemed Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
